HEXACOSANOIC ACID

HEXACOSANOIC ACID is a lipid of Fatty Acyls (FA) class. Hexacosanoic acid is associated with abnormalities such as Adrenoleukodystrophy, Adrenal gland hypofunction and Chronic liver disease NOS. The involved functions are known as peroxisome targeting signal-2 binding activity, Oxidation, Demyelination, Mutation and Biosynthetic Pathways. Hexacosanoic acid often locates in peroxisome, Body tissue, Mitochondria, Membrane and Cytoplasm. The associated genes with HEXACOSANOIC ACID are ABCD1 gene, TRAM1 gene, GPX1 gene, SOD1 gene and SOD2 gene. The related lipids are Fatty Acids, Stearic acid, inositolphosphorylceramide, Very long chain fatty acid and Nonesterified Fatty Acids. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of HEXACOSANOIC ACID, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with HEXACOSANOIC ACID?

HEXACOSANOIC ACID is suspected in Adrenoleukodystrophy, Adrenal gland hypofunction, Chronic liver disease NOS and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with HEXACOSANOIC ACID

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Liver Diseases D008107 31 associated lipids
Kidney Diseases D007674 29 associated lipids
Leukemia P388 D007941 43 associated lipids
Metabolism, Inborn Errors D008661 46 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Diffuse Cerebral Sclerosis of Schilder D002549 8 associated lipids
Arteriosclerosis D001161 86 associated lipids
Metabolic Diseases D008659 12 associated lipids
Adrenocortical Hyperfunction D000308 3 associated lipids
Per page 10 20 | Total 17

PubChem Associated disorders and diseases

What pathways are associated with HEXACOSANOIC ACID

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with HEXACOSANOIC ACID?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with HEXACOSANOIC ACID?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with HEXACOSANOIC ACID?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with HEXACOSANOIC ACID?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with HEXACOSANOIC ACID?

Knock-out

Knock-out are used in the study 'A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis.' (Fourcade S et al., 2009).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with HEXACOSANOIC ACID

Download all related citations
Per page 10 20 50 100 | Total 136
Authors Title Published Journal PubMed Link
Boggs JM et al. Influence of structural modifications on the phase behavior of semi-synthetic cerebroside sulfate. 1988 Biochim. Biophys. Acta pmid:3349071
Sano M et al. [Two adult cases of adrenoleukodystrophy with clinical features of striatonigral degeneration--a probable variant of adrenoleukodystrophy]. 1988 Rinsho Shinkeigaku pmid:3246111
Kawahara K et al. Hexacosanoate contents in Japanese common foods. 1988 J. Nutr. Sci. Vitaminol. pmid:3244051
Wanders RJ et al. Peroxisomal fatty acid beta-oxidation in relation to the accumulation of very long chain fatty acids in cultured skin fibroblasts from patients with Zellweger syndrome and other peroxisomal disorders. 1987 J. Clin. Invest. pmid:3680527
Tanaka K et al. Electronmicroscopic study on biopsied rectal mucosa in adrenoleukodystrophy. 1987 Neurology pmid:3587618
Watkins PA et al. Adrenoleukodystrophy: biochemical procedures in diagnosis, prevention and treatment. 1987 J. Inherit. Metab. Dis. pmid:3119941
Rizzo WB et al. Adrenoleukodystrophy: dietary oleic acid lowers hexacosanoate levels. 1987 Ann. Neurol. pmid:3037987
Sereni C et al. Adult adrenoleukodystrophy: a sporadic case? 1987 J. Neurol. Sci. pmid:3681326
Moser HW Adrenoleukodystrophy: from bedside to molecular biology. 1987 J. Child Neurol. pmid:3598142
Wanders RJ et al. Prenatal diagnosis of Zellweger syndrome by measurement of very long chain fatty acid (C26:0) beta-oxidation in cultured chorionic villous fibroblasts: implications for early diagnosis of other peroxisomal disorders. 1987 Clin. Chim. Acta pmid:3652452
Moser AB et al. A new dietary therapy for adrenoleukodystrophy: biochemical and preliminary clinical results in 36 patients. 1987 Ann. Neurol. pmid:2440378
Singh H et al. Beta-oxidation of very-long-chain fatty acids and their coenzyme A derivatives by human skin fibroblasts. 1987 Arch. Biochem. Biophys. pmid:2437859
Lambert MA et al. Analysis of mycolic acid cleavage products and cellular fatty acids of Mycobacterium species by capillary gas chromatography. 1986 J. Clin. Microbiol. pmid:3084554
Rizzo WB et al. Adrenoleukodystrophy: oleic acid lowers fibroblast saturated C22-26 fatty acids. 1986 Neurology pmid:3951702
Tsuji S et al. Metabolism of [17,18-3H2]hexacosanoic acid and [15,16-3H2]lignoceric acid in cultured skin fibroblasts from patients with adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN). 1985 J. Neurol. Sci. pmid:4087029
Turpin JC et al. [Adult disclosure of a case of familial adrenoleukodystrophy]. 1985 Rev. Neurol. (Paris) pmid:2990005
Boué J et al. First trimester prenatal diagnosis of adrenoleukodystrophy by determination of very long chain fatty acid levels and by linkage analysis to a DNA probe. 1985 Hum. Genet. pmid:3856557
Govaerts L et al. Disturbed very long chain (C24-C26) fatty acid pattern in fibroblasts of patients with Zellweger's syndrome. 1985 J. Inherit. Metab. Dis. pmid:3921760
Krause KH et al. [EMG and evoked potentials in adrenomyeloneuropathy]. 1985 EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb pmid:3930208
Sakai T et al. Very long-chain fatty acids in neutral lipids and glycerophospholipids of adrenoleukodystrophy-cultured skin fibroblasts. 1985 J. Neurol. Sci. pmid:4087027
Bakkeren JA et al. Serum very long chain fatty acid pattern in Zellweger syndrome. 1984 Clin. Chim. Acta pmid:6723067
Pretorius PJ et al. Biochemical evidence for clinically diagnosed adrenoleucodystrophy in two brothers. 1984 S. Afr. Med. J. pmid:6729621
Moser AE et al. The cerebrohepatorenal (Zellweger) syndrome. Increased levels and impaired degradation of very-long-chain fatty acids and their use in prenatal diagnosis. 1984 N. Engl. J. Med. pmid:6709009
Van Duyn MA et al. The design of a diet restricted in saturated very long-chain fatty acids: therapeutic application in adrenoleukodystrophy. 1984 Am. J. Clin. Nutr. pmid:6465061
Moser HW et al. Adrenoleukodystrophy: survey of 303 cases: biochemistry, diagnosis, and therapy. 1984 Ann. Neurol. pmid:6524872
Poulos A and Sharp P Plasma and skin fibroblast C26 fatty acids in infantile Refsum's disease. 1984 Neurology pmid:6209596
Moser HW et al. The prenatal diagnosis of adrenoleukodystrophy. Demonstration of increased hexacosanoic acid levels in cultured amniocytes and fetal adrenal gland. 1982 Pediatr. Res. pmid:7063272
Moser HW et al. Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids. 1981 Neurology pmid:7202134
Tsuji S et al. Increased synthesis of hexacosanoic acid (C23:0) by cultured skin fibroblasts from patients with adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN). 1981 J. Biochem. pmid:7309718
Molzer B et al. Fatty acid patterns in brain, fibroblast, leukocyte and body fluid lipids in adrenoleukodystrophy. 1981 Acta Neuropathol Suppl pmid:6939237
Gunasekera SP et al. Constituents of Nealchornea yapurenis (Euophorbiaceae). 1980 Mar-Apr J. Nat. Prod. pmid:7381509
Moser HW et al. Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts. 1980 Ann. Neurol. pmid:7436359
Kishimoto Y et al. Adrenoleukodystrophy: evidence that abnormal very long chain fatty acids of brain cholesterol esters are of exogenous origin. 1980 Biochem. Biophys. Res. Commun. pmid:7437052
Kawamura N et al. High concentration of hexacosanoate in cultured skin fibroblast lipids from adrenoleukodystrophy patients. 1978 Biochem. Biophys. Res. Commun. pmid:666828
Deng F et al. New flavonoids and other constituents from Lespedeza cuneata. J Asian Nat Prod Res pmid:17943561
pmid: